Knowledge & Resources
Expert insights and knowledge on global Innovative Contracting, VBA,
Market Access and Human Performance Factors
Innovative Contracting & VBA
Articles & Whitepapers
Inside IPAY2026: What CMS’s Redacted Files Reveal About Negotiation Strategies
The IPAY2026 redacted files are out—and they reveal more than you might expect. From CMS’s structured approach to the dynamic role of commercial net price in negotiations, we have analyzed these insights to prepare pharma manufacturers for what lies ahead. The question remains: Are you ready for IPAY2027?
Top Ten Learnings & Recommendations for Manufacturers Following the First Wave of the Medicare Drug Price Negotiation Program
Valuable guidance for manufacturers, from our top ten learnings drawn from our experience supporting manufacturers during the Medicare Drug Price Negotiation Program
Indication-Based Pricing: The Simplest Explanation You’ll Ever Read
We examine the complexities of pricing pharmaceuticals with multiple uses or "indications". In contrast with uniform pricing, 'indication-based pricing' (IBP) aligns price with value for each use. We explore successful IBP strategies, challenges like legislative barriers and complex data collection, and discover how IBP benefits both healthcare systems and patients.